PAMELA JONES: Open Payments
NPI 1326236597 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,044 in 103 payments from 16 companies in 2025. Trend: 2023 $5,464 · 2024 $3,454 · 2025 $6,044
Consulting: $3,332Food & beverage: $2,345Travel & lodging: $367
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $2,863 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $1,441 |
| Sumitomo Pharma America, Inc. | 38 | $617 |
| Dendreon Pharmaceuticals LLC | 14 | $223 |
| Janssen Biotech, Inc. | 4 | $183 |
| BIOPROTECT MEDICAL, INC. | 1 | $165 |
| Merck Sharp & Dohme LLC | 3 | $161 |
| UROGEN PHARMA, INC. | 5 | $132 |
| AstraZeneca Pharmaceuticals LP | 5 | $112 |
| Astellas Pharma US Inc | 2 | $39 |
Products named: ORGOVYX, PROVENGE, XTANDI, ERLEADA, BIOPROTECT BALLOON IMPLANT SYSTEM, KEYTRUDA, JELMYTO, LYNPARZA.
Industry payments across MI — which companies pay providers there.
